Lowe’s Lowers Full Year 2024 Outlook on Weak DIY Sales

Image: Lowe’s shares have traded sideways since the beginning of 2022. By Brian Nelson, CFA On August 20, Lowe’s (LOW) reported mixed second quarter results with revenue coming in below expectations and the firm’s non-GAAP earnings per share exceeding the consensus forecast. Total sales during the quarter fell 5.5%, while comparable sales for the quarter fell 5.1% “driven by continued pressure in DIY (do-it-yourself) bigger ticket discretionary spending and unfavorable weather adversely impacting sales in seasonal and other outdoor categories.” Adjusted diluted earnings per share fell to $4.10 per share in the second quarter from $4.56 per share in the second quarter of 2023. During the second quarter, Lowe’s bought back roughly 4.4 million shares of stock for $1 billion, … Read more

Gilead Raises Non-GAAP Diluted Earnings Outlook for 2024

Image Source: Gilead By Brian Nelson, CFA Gilead Sciences (GILD) reported better than expected second quarter results on August 8. Total second quarter revenue increased 5% thanks to higher sales across its HIV, Liver Disease and Oncology portfolio, while non-GAAP diluted earnings per share came in at $2.01 in the second quarter of 2024, compared to $1.34 in the same quarter of 2023. Total product sales increased 6%, excluding its COVID-19-related treatment Veklury. Management had the following to say about the quarter: Gilead has had another strong quarter with 6% year-over-year growth in our base business. This was driven by sales of our therapies for HIV, Oncology and Liver Disease, including 8% growth for Biktarvy. One of the key highlights … Read more

Energy Transfer Raises 2024 Adjusted EBITDA Guidance, Units Yield 7.8%

Image Source: Energy Transfer By Brian Nelson, CFA Energy Transfer (ET) reported strong second quarter results on August 7. Net income attributable to partners totaled $1.31 billion in the quarter, up from $911 million in the same quarter a year ago. Net income per common unit on a diluted basis expanded to $0.35 from $0.25 in last year’s quarter. Adjusted EBITDA in its June quarter was $3.76 billion compared to $3.12 billion for the same three months of last year. Distributable cash flow [DCF] to partners came in at $2.039 billion in the quarter compared to $1.554 billion in last year’s period. Total distributions to be paid to partners was $1.1 billion in the quarter, translating into excellent distribution coverage … Read more

Deere’s Fiscal Third Quarter Results Reveal Challenging Conditions in the Global Agricultural and Construction Sectors

Image Source: Deere & Company By Brian Nelson, CFA Deere & Company (DE) reported better than expected fiscal third quarter results on August 15 with revenue and GAAP earnings per share coming ahead of the consensus forecasts. Worldwide net sales and revenues fell 17% on a year-over-year basis, accelerating from the 11% fall through the first nine months of the year, but this was better than feared. Net income of $6.29 per share in the quarter fell from $10.20 per share in the quarter ended July 30, 2023. Net income dropped 42% on a year-over-year basis. Management’s commentary was cautious in the press release: John Deere’s third-quarter results showcase our disciplined execution in the face of challenging conditions in the … Read more

Walmart Raises Its Fiscal 2025 Outlook

Image Source: Walmart By Brian Nelson, CFA On August 15, Walmart (WMT) reported better than expected second quarter results with both revenue and non-GAAP earnings per share coming in higher than the consensus forecast. Consolidated revenue advanced 4.8% in the quarter led by Walmart U.S. comp sales up 4.2% and Sam’s Club comp sales up 5.2%, both measures excluding fuel. The company’s consolidated gross margin expanded 43 basis points thanks to strength in Walmart U.S. and Walmart International. Walmart’s adjusted operating income increased 7.2% in the quarter “due to higher gross margins and growth in membership income.” Global ecommerce and global advertising advanced 21% and 26%, respectively, in the period. Adjusted earnings per share increased 9.8%, to $0.67 per share, … Read more

Cisco’s Fiscal Fourth Quarter Results Exceed Expectations

Image Source: Cisco By Brian Nelson, CFA On August 14, Cisco Systems (CSCO) reported better than expected fiscal fourth quarter results with both revenue and non-GAAP earnings per share coming in higher than the consensus forecasts. Revenue fell 10% on a year-over-year basis, while non-GAAP earnings per share dropped 24% from the same period last year. Fiscal fourth quarter non-GAAP gross margin was 67.9%, and the company now has total annualized recurring revenue of $29.6 billion, up 22% year-over-year inclusive of its acquisition of Splunk. The company’s product order growth was 14% in the quarter. Management’s commentary in the press release was positive: We delivered a strong close to fiscal 2024. In our fourth quarter, we saw steady customer demand … Read more

Home Depot’s Results Show Weaker Spending on Home Improvement Projects

Image: Home Depot’s shares have been choppy the past few years. By Brian Nelson, CFA On August 13, Home Depot (HD) reported better-than-expected second quarter results with both its top line and non-GAAP earnings per share coming in higher than the consensus forecast. Comparable sales for the second quarter of fiscal 2024 fell 3.3%, while U.S. comparable sales slid 3.6%, however. Adjusted operating income for the second quarter was roughly flat with the year-ago period, while adjusted operating margin contracted approximately 20 basis points, to 15.3%. Adjusted net earnings nudged slightly lower in the second quarter, to $4.67 from $4.68 in the same period last year. Management’s commentary in the press release was cautious: The underlying long-term fundamentals supporting home … Read more

Procter & Gamble’s Organic Growth Fails to Impress

By Brian Nelson, CFA Procter & Gamble (PG) recently reported fiscal fourth quarter results that showed a miss on the top line, but non-GAAP earnings per share coming in better than expectations. The company reported flat sales performance during the June quarter as modest volume and higher pricing were offset by two percentage points of unfavorable foreign exchange impacts. Organic sales growth was 2% in the quarter. Core net earnings per share also increased 2%, to $1.40. Currency-neutral core EPS increased 6% versus the prior-year quarter. Management had a lot to say in the press release: Fiscal year 2024 was another year of strong results for P&G. The team met or exceeded our going-in plans for organic sales growth, core … Read more

Starbucks’ Mixed Results Speak to Cautious Consumer Environment

By Brian Nelson, CFA Starbucks (SBUX) recently reported mixed fiscal third quarter results with non-GAAP earnings per share coming in line with the consensus estimate, while revenue came up short. Global comparable store sales declined 3% in the 13-week period ended June 30, 2024, as comparable transactions declined 5%, while average ticket advanced 2%. Non-GAAP earnings per share of $0.93 fell 7% over the prior-year quarter (down 6% on a constant currency basis). Though Starbucks’ fiscal third quarter was mixed, we’re sticking with our $85 per-share fair value estimate for shares. Starbucks experienced weakness across both its North America stores and its International stores. North America comparable store sales fell 2% as a 3% increase in average ticket failed to … Read more

Eli Lilly Puts Up Strong Second Quarter Results, Raises Outlook

Image: Shares of Eli Lilly have been strong the past few years. By Brian Nelson, CFA Eli Lilly (LLY) reported better than expected second quarter results on August 8 with both revenue and non-GAAP earnings per share coming in better than the consensus forecast. Revenue jumped 36% in the quarter on a year-over-year basis thanks to strength in Mounjaro, Zepbound, and Verzenio. Volume increased 27%, while the company experienced a 10% increase in realized prices, offset by a 1% headwind with respect to foreign exchange. Non-GAAP net income and earnings per share both increased 86% in what was a blockbuster report from the pharma giant. Management had the following to say about the strong performance: Mounjaro, Zepbound and Verzenio led … Read more